SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-21-042683
Filing Date
2021-08-16
Accepted
2021-08-16 08:41:15
Documents
69
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0621_180lifesciences.htm   iXBRL 10-Q 966339
2 FORM OF STOCK OPTION AGREEMENT (INDEPENDENT DIRECTORS AUGUST 2021 GRANTS) f10q0621ex10-9_180lifesci.htm EX-10.9 87471
3 CERTIFICATION f10q0621ex31-1_180lifesci.htm EX-31.1 10830
4 CERTIFICATION f10q0621ex31-2_180lifesci.htm EX-31.2 10518
5 CERTIFICATION f10q0621ex32-1_180lifesci.htm EX-32.1 3887
6 CERTIFICATION f10q0621ex32-2_180lifesci.htm EX-32.2 3793
12 GRAPHIC image_001.jpg GRAPHIC 2410
  Complete submission text file 0001213900-21-042683.txt   5779427

Data Files

Seq Description Document Type Size
7 XBRL PRESENTATION FILE atnf-20210630_pre.xml EX-101.PRE 323390
8 XBRL LABEL FILE atnf-20210630_lab.xml EX-101.LAB 633972
9 XBRL DEFINITION FILE atnf-20210630_def.xml EX-101.DEF 306581
10 XBRL CALCULATION FILE atnf-20210630_cal.xml EX-101.CAL 34882
11 XBRL SCHEMA FILE atnf-20210630.xsd EX-101.SCH 85668
13 EXTRACTED XBRL INSTANCE DOCUMENT f10q0621_180lifesciences_htm.xml XML 601155
Mailing Address 830 MENLO AVENUE, SUITE 100 MENLO PARK CA 94025
Business Address 830 MENLO AVENUE, SUITE 100 MENLO PARK CA 94025 650-507-0669
180 Life Sciences Corp. (Filer) CIK: 0001690080 (see all company filings)

IRS No.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38105 | Film No.: 211174774
SIC: 2834 Pharmaceutical Preparations